Three of a family from Ullal killed in ghastly mishap near Mysuru; several injured

New Delhi, Jul 9: India reported the highest single-day spike of 24,879 new positive cases and 487 deaths in the last 24 hours, taking the total number of COVID-19 cases in the country to 7,67,296, according to the Union Ministry of Health and Family Welfare.

Out of the total number of cases, 2,69,789 are active, 4,76,378 have been cured/discharged/migrated and 21,129 have died.

Maharashtra remains the worst-affected state due to COVID-19 with as many as 2,23,724 cases, including 91,084 active, 1,23,192 cured/discharged and 9,448 deaths.

It is followed by Tamil Nadu (1,22,350) and Delhi (1,04,864).

Meanwhile, a total of 1,07,40,832 samples have been tested for COVID-19 till July 8. Of these, 2,67,061 samples were tested yesterday, stated Indian Council of Medical Research (ICMR).

Bengaluru, Apr 30: Four ministers of Karnataka have gone into self-quarantine after they got here in touch with a video journalist of native channel who has examined optimistic for COVID-19. The listing contains state’s Deputy Chief Minister Dr Ashwath Narayan.

All 4 introduced the quarantine on Twitter.

Mr Narayan, dwelling minister Basvaraj Bommai , medical training Minister Dr. Sudhakar and tourism minister CT Ravi tweeted to say that they’ve examined detrimental for coronavirus however will likely be beneath self-quarantine.

They mentioned they got here in touch with a video journalist from a neighborhood tv channel  who was discovered COVID-19 optimistic on April 24. He had met the ministers between April 21 and April 24.

At least 40 different contacts of the video journalist, together with his household and journalists from numerous media retailers have been quarantined, reported news agency.

Earlier this month, Gujarat Chief Minister Vijay Rupani put himself in quarantine after an MLA who attended a gathering with him turned out to be coronavirus-positive.

Karnataka to date had 532 circumstances of coronavirus. Of them, 215 sufferers recovered and 20 sufferers died.

Earlier immediately, the state authorities determined to chill out lockdown restrictions in plenty of districts the place the coronavirus has not had a serious affect. The authorities is permitting industries to operate in these areas with sure circumstances.

The listing contains spots in Chamarajnagar, Koppal, Chikmagaluru, Raichur, Chitradurga, Hassan, Shivamogga, Haveri, Yadgir, Kolar, Udupi, Davanagere and Kodagu districts.

Manufacturing will likely be allowed within the particular financial zones in these districts and standalone outlets exterior municipal limits will likely be allowed to operate.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.